ӢQ(chng):N2-(1S-Ethoxycarbonyl-3-phenylpropyl)-N6-trifluoroacetyl-L-lysineӢͬx~:N2-((1,S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-N-TRIFLUOROACETYL-2-LYSINE
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0098998 | 100mg |
1
|
ԃ(xn)r(ji) |
Q-0098998 | 250mg |
1
|
ԃ(xn)r(ji) |
Q-0098998 | 500mg |
1
|
ԃ(xn)r(ji) |
Q-0098998 | 1g |
1
|
ԃ(xn)r(ji) |
Q-0098998 | 5g |
1
|
ԃ(xn)r(ji) |

N2-(1-ʻ-3-)-N6--L-ه(li)
Ӣ N2-(S)-1-Ethoxycarbonyl-3-phenylpropyl-N8-trifluoroacetyl-L-lysine
Ąe N2-(1-(S)-ʻ-3-)-N6--L-ه(li) | ه(li)Zgw
W(xu)|(zh)
ܶ 1.234 g/cm3
c(din) 586.987ºC at 760 mmHg
c(din) 134-136ºC
ʽ C20H27F3N2O5
432.43400
Wc(din) 308.799ºC
|(zh) 432.18700
PSA 104.73000
LogP 3.22430
^Ԡ ɫw
;
B(ti)w/ĩ/Һ
a(chn)أ
(ch)r(sh)g1
棺
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
ӢQ(chng):3'-Fluoro-5'-(trifluoroMethoxy)acetophenone,97%Ӣͬx~:3'-Fluoro-5'-(trifluoroMethoxy)acetophenone,97%;1-[3-Fluoro-5-(trifluoromethoxy)phenyl]ethanone
-
ӢQ(chng):(R)-(+)-3-CYCLOHEXENECARBOXYLICACIDӢͬx~:(R)-(+)-1,2,3,6-Tetrahydrobenzoicacid;(1R)-cyclohex-3-ene-1-carboxylicacid;(R)-Cyclohex-3-enecarboxylicacid